Group One Trading’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-63,692
| Closed | -$216K | – | 7945 |
|
|
2025
Q4 | $233K | Buy |
63,692
+48,310
| +314% | +$138K | ﹤0.01% | 4234 |
|
|
2025
Q3 | $56.8K | Buy |
+15,382
| New | +$38.9K | ﹤0.01% | 5845 |
|
|
2025
Q2 | – | Sell |
-44,820
| Closed | -$77.6K | – | 8111 |
|
|
2025
Q1 | $69.9K | Buy |
44,820
+15,124
| +51% | +$26.7K | ﹤0.01% | 4895 |
|
|
2024
Q4 | $60.1K | Buy |
29,696
+4,000
| +16% | +$7.25K | ﹤0.01% | 4917 |
|
|
2024
Q3 | $37.1K | Buy |
25,696
+14,800
| +136% | +$28.2K | ﹤0.01% | 4843 |
|
|
2024
Q2 | $18.6K | Buy |
10,896
+10,000
| +1,116% | +$18.1K | ﹤0.01% | 5277 |
|
|
2024
Q1 | $1.79K | Buy |
896
+863
| +2,615% | +$1.72K | ﹤0.01% | 6511 |
|
|
2023
Q4 | $99 | Sell |
33
-100
| -75% | -$264 | ﹤0.01% | 7197 |
|
|
2023
Q3 | $581 | Hold |
133
| – | – | ﹤0.01% | 7313 |
|
|
2023
Q2 | $1.1K | Hold |
133
| – | – | ﹤0.01% | 7242 |
|
|
2023
Q1 | $1.64K | Buy |
+133
| New | +$1.58K | ﹤0.01% | 6656 |
|
|
2022
Q4 | – | Sell |
-133
| Closed | -$2K | – | 7478 |
|
|
2022
Q3 | $2K | Hold |
133
| – | – | ﹤0.01% | 7141 |
|
|
2022
Q2 | $2K | Buy |
+133
| New | +$1.97K | ﹤0.01% | 7397 |
|
|
2022
Q1 | – | Sell |
-978
| Closed | -$37K | – | 8214 |
|
|
2021
Q4 | $37K | Buy |
978
+520
| +114% | +$23.2K | ﹤0.01% | 6546 |
|
|
2021
Q3 | $22K | Sell |
458
-217
| -32% | -$10.6K | ﹤0.01% | 7111 |
|
|
2021
Q2 | $36K | Buy |
+675
| New | +$40.7K | ﹤0.01% | 6827 |
|
|
2017
Q2 | – | Sell |
-33
| Closed | -$1.95K | – | 4836 |
|
|
2017
Q1 | $2K | Sell |
33
-448
| -93% | -$20K | ﹤0.01% | 4446 |
|
|
2016
Q4 | $19K | Hold |
481
| – | – | ﹤0.01% | 3716 |
|
|
2016
Q3 | $21K | Buy |
+481
| New | +$20.5K | ﹤0.01% | 3758 |
|
|
2015
Q3 | – | Sell |
-174
| Closed | -$9K | – | 4937 |
|
|
2015
Q2 | $9K | Buy |
+174
| New | +$8.93K | ﹤0.01% | 4324 |
|
|
2014
Q4 | – | Sell |
-8,546
| Closed | -$252K | – | 5009 |
|
|
2014
Q3 | $269K | Buy |
8,546
+1,648
| +24% | +$43.8K | ﹤0.01% | 2140 |
|
|
2014
Q2 | $178K | Buy |
+6,898
| New | +$182K | ﹤0.01% | 2524 |
|
|
2014
Q1 | – | Sell |
-800
| Closed | -$31.2K | – | 5303 |
|
|
2013
Q4 | $32K | Buy |
800
+569
| +246% | +$22K | ﹤0.01% | 3964 |
|
|
2013
Q3 | $24K | Sell |
231
-2,182
| -90% | -$268K | ﹤0.01% | 4056 |
|
|
2013
Q2 | $311K | Buy |
+2,413
| New | +$356K | 0.01% | 1763 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Group One Trading's FBIO Position: Q1 2026 in Review
Group One Trading sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 63,692 shares — an estimated $216K sold.
Group One Trading first reported a position in FBIO in Q2 2013 and held it in 25 quarters. The position peaked at $311K in Q2 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Group One Trading reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 63,692 Fortress Biotech shares in Q1 2026, an estimated $216K.
- Group One Trading first reported a position in Fortress Biotech in Q2 2013 and held it in 25 quarters.
- Group One Trading's Fortress Biotech position peaked at $311K in Q2 2013.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.